SCHEMBL9538457

SCHEMBL9538457

CC1(C)Nc2ccc(N)c(Br)c2[N]C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL9354927 0.98
SCHEMBL9354714 0.69 CA9 (0.33)
Bromide SCHEMBL7758524 0.69 AKR1B1 (0.30)
SCHEMBL9354703 0.59 MAPT (0.53)
SCHEMBL992469 0.59
SCHEMBL22366550 0.57 IMPDH2 (0.42)
SCHEMBL8304624 0.56 MMP12 (0.38)
SCHEMBL31394896 0.55 TGM2 (0.50)
SCHEMBL3594074 0.55 CA9 (0.40)
SCHEMBL3596380 0.55 CA9 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0549594-A1 (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES AND METHODS FOR USING SAME. ALLERGAN INC (US) 1993-07-07 EP disclosed
EP-0549594-A4 (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES AND METHODS FOR USING SAME. ALLERGAN INC (US) 1993-04-16 EP disclosed
WO-1992002515-A1 (2-IMIDAZOLIN-2-YLAMINO) QUINOXALINE DERIVATIVES AND METHODS FOR USING SAME ALLERGAN, INC. (US) 1992-02-20 WO disclosed